AGEN
Price
$4.55
Change
-$0.21 (-4.41%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
124.75M
ATRA
Price
$7.71
Change
-$0.24 (-3.02%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
45.96M
Interact to see
Advertisement

AGEN vs ATRA

Header iconAGEN vs ATRA Comparison
Open Charts AGEN vs ATRABanner chart's image
Agenus
Price$4.55
Change-$0.21 (-4.41%)
Volume$10.58K
Capitalization124.75M
Atara Biotherapeutics
Price$7.71
Change-$0.24 (-3.02%)
Volume$200
Capitalization45.96M
AGEN vs ATRA Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. ATRA commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and ATRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (AGEN: $4.76 vs. ATRA: $7.96)
Brand notoriety: AGEN and ATRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 326% vs. ATRA: 38%
Market capitalization -- AGEN: $124.75M vs. ATRA: $45.96M
AGEN [@Biotechnology] is valued at $124.75M. ATRA’s [@Biotechnology] market capitalization is $45.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • ATRA’s FA Score: 0 green, 5 red.
According to our system of comparison, AGEN is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while ATRA’s TA Score has 3 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • ATRA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than ATRA.

Price Growth

AGEN (@Biotechnology) experienced а -0.42% price change this week, while ATRA (@Biotechnology) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

AGEN is expected to report earnings on May 12, 2025.

ATRA is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($125M) has a higher market cap than ATRA($46M). AGEN YTD gains are higher at: 73.723 vs. ATRA (-40.195). ATRA has higher annual earnings (EBITDA): -5.74M vs. AGEN (-81.06M). AGEN has more cash in the bank: 18.5M vs. ATRA (13.8M). ATRA has less debt than AGEN: ATRA (40.6M) vs AGEN (92M). ATRA has higher revenues than AGEN: ATRA (200M) vs AGEN (99.5M).
AGENATRAAGEN / ATRA
Capitalization125M46M272%
EBITDA-81.06M-5.74M1,411%
Gain YTD73.723-40.195-183%
P/E Ratio0.15N/A-
Revenue99.5M200M50%
Total Cash18.5M13.8M134%
Total Debt92M40.6M227%
FUNDAMENTALS RATINGS
AGEN vs ATRA: Fundamental Ratings
AGEN
ATRA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3555
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRA's Valuation (74) in the Biotechnology industry is in the same range as AGEN (97). This means that ATRA’s stock grew similarly to AGEN’s over the last 12 months.

ATRA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that ATRA’s stock grew similarly to AGEN’s over the last 12 months.

ATRA's SMR Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that ATRA’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (35) in the Biotechnology industry is in the same range as ATRA (55). This means that AGEN’s stock grew similarly to ATRA’s over the last 12 months.

AGEN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ATRA (100). This means that AGEN’s stock grew similarly to ATRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENATRA
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 22 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LINC23.800.80
+3.48%
Lincoln Educational Services Corp
GROW2.540.06
+2.42%
US Global Investors
MCRI87.180.90
+1.04%
Monarch Casino & Resort
REYN21.300.03
+0.14%
Reynolds Consumer Products
DELL123.99-1.99
-1.58%
Dell Technologies

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-3.05%
SNPX - AGEN
91%
Closely correlated
+23.37%
ALLR - AGEN
87%
Closely correlated
+1.00%
NRXP - AGEN
83%
Closely correlated
-2.29%
PALI - AGEN
81%
Closely correlated
-1.93%
CCCC - AGEN
43%
Loosely correlated
-7.89%
More

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+0.13%
IKNA - ATRA
72%
Closely correlated
+1.49%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
-13.36%
PHAT - ATRA
36%
Loosely correlated
+1.99%
LENZ - ATRA
33%
Loosely correlated
+0.23%
More